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Abstract
Androgen deprivation therapy is the most common treatment option for advanced prostate cancer.
Almost all prostate cancers recur during androgen deprivation therapy, and new evidence suggests
that androgen receptor activation persists despite castrate levels of circulating androgens.
Quantitation of tissue levels of androgens is critical to understanding the mechanism of recurrence
of prostate cancer during androgen deprivation therapy. A liquid chromatography atmospheric
pressure photoionization tandem mass spectrometric method was developed for quantitation of
tissue levels of androgens. Quantitation of the saturated keto-steroids dihydrotestosterone and 5-α-
androstanedione required detection of a novel parent ion, [M + 15]+. The nature of this parent ion
was explored and the method applied to prostate tissue and cell culture with comparison to results
achieved using electrospray ionization.
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Introduction
The American Cancer Society estimated that 192,280 new cases of prostate cancer (CaP)
and 27,360 deaths related to CaP would occur in 2009.1 Androgen deprivation therapy
(ADT) offers palliation for advanced CaP2, but no significant improvements have been
made in the 60 years since its discovery. CaP recurs eventually in almost all cases treated by
ADT and these cases of recurrent CaP respond poorly to all known therapies and usually
cause death. Recurrent CaP has historically been thought of as androgen-independent
because CaP recurs during ADT. Evidence of androgen receptor (AR) activation in recurrent
CaP has led to hypotheses involving altered cellular androgen metabolism and AR-
signaling. In addition, growing evidence suggests that intracrine synthesis of testicular
androgens allow AR activation in recurrent CaP.3, 4 However, low tissue concentrations of
testicular androgens in the castrate male necessitate sensitive analytical techniques for study
of changes in androgen metabolism that occur in response to ADT.
Radioimmunoassay (RIA) was used for the detection and quantitation of androgens in
prostate tissues by Mohler, et al., who found that levels of testosterone (T) were similar in
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CaP recurrent during ADT and androgen stimulated CaP and benign prostate hyperplasia.5
Dihydrotestosterone (DHT), the preferred ligand of AR, concentrations were reduced during
ADT, but still averaged 1.45 nM in recurrent CaP, a concentration sufficient to activate
normal androgen receptor. RIA requires pre-separation of the targeted androgens, which can
lead to analyte loss, and is subject to interference via non-specific binding. Liquid
chromatography tandem mass spectrometry (LC/MS/MS) offers advantages over RIA,
which include simpler sample preparation and greater reproducibility, accuracy, and
specificity.6 The presence of DHT in ADT recurrent CaP tissue suggested by RIA
measurement was confirmed using LC/ESI/MS/MS. 7
In androgen responsive tissues, intracellular T acts as a prohormone that is converted to
DHT. In the prostate, the enzyme steroid 5α-reductase (SRD5A; EC 1.3.99.5)
(http://www.genome.jp/kegg/pathway/map/map00150.html) metabolizes testosterone to
DHT. SRD5A inhibitors, finasteride against SRD5A type 2 and dutasteride against SRD5A
types 1 and 2, have proven useful for treatment of benign prostate enlargement and are
under investigation for prostate cancer prevention and treatment of androgen-stimulated and
recurrent CaP.8-13 Continued investigation of new therapies for benign and malignant
prostate disease requires accurate measurement of T, DHT and other androgens in prostate
tissue.
Determination of T and DHT in samples using LC/ESI/MS/MS is quite sensitive, but the
necessity of measuring tissue androgens in small samples, such as prostate biopsies and
microdissected radical prostectomy specimens, limits the usefulness of existing methods. In
addition, more sensitive detection and quantification of other steroid compounds is
important to fully characterize tissue metabolism of androgens. For example, quantitation of
androstenedione (ASD), 5α-androstan-3α, 17β-diol (5α-diol), 5-androsten-3β-ol-17-one
(dehydroepiandrosterone, DHEA), 5α-androstanedione (5α-ASD), and 5α-androstan-3α-
ol-17-one (androsterone, AND) is important for understanding the origin and fate of
potential AR ligands, especially during androgen deprivation therapy. The characterization
of the entire androgen metabolism pathway has become more important because drugs, such
as abiraterone14 and VN124/TOK00115, both of which are in clinical trials, have been
developed that interfere with synthesis of DHT from adrenal androgens. The monitoring of
multiple androgens in prostate tissue may raise the limits of quantitation (LOQ) of the
individual analytes when using a quadrupole mass analyzer. Therefore, research into
intracrine metabolism of steroid hormones in prostate and other hormonally-responsive
cancers requires improved sensitivity of detection of low levels of androgens and other
steroid hormones in biological samples.
A number of articles reporting improved MS sensitivity for steroids have appeared in the
literature. Zhao, et al., reported the simultaneous quantification of steroid hormones in
human testicular fluid using an LC/ESI/MS/MS method.16 They reported improved limits of
quantitation (S/N>5) of 0.1 ng/mL for T and of 0.02 ng/mL for DHT (on a Micromass
Quattro triple-quadrupole). Atmospheric pressure photoionization (APPI)17-20 has been
reported to increase sensitivity for unsaturated keto-steroids. For example, Guo, et al.,
reported the quantitation of 12 steroids using isotope dilution LC/APPI/MS/MS on either a
Sciex API300021 or 5000.22 These 12 analytes included analytes that are implicated in
androgen metabolism, such as T, ASD, and DHEA, with limits of detection on the newer
instrument (3 SDs over the baseline noise) of 1.5, 1.5, and 10.0 pg/mL, respectively.
Recently, Zhang and co-workers used direct derivatization (dansylation) to quantitate four
steroids: testosterone, 11-ketotestosterone, estradiol and ethinyl estradiol. They reported
results from 10 μL of fish plasma with an LOQ of 1 ng/mL for T (S:N = 8).23 The authors
note that the 10 μL sample size is 5-50 fold less than most published methods. These results,
although on instruments of different vintages, indicate increased sensitivity for T under
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APPI conditions than with ESI. Several studies have utilized APPI to identify and quantitate
steroids22, 24-27, but none of these included DHT as an analyte. The omission of DHT in
these reports may be due to the poor yield of DHT [M + H]+ ions from the APPI source, and
illustrates a limitation of the use of APPI for comprehensive steroid quantification.
In this study, we report an LC/APPI/MS/MS method for the quantification of seven
intracellular androgens. The requisite sensitivity for the saturated keto-steroids DHT and 5α-
ASD is achieved through the selection of a novel [M + 15]+ parent ion. The origin of this
ion is also reported.
Materials
Chemicals
Deuterated T and DHT (d3-16,16,17α) were purchased from CDN isotopes (Pointe-Claire,
Quebec, CA). 1,2,4,5-d4-DHT, 5α-androstan-3-one, 5α-cholestan-3-one, 5β-cholestan-3-
one, and 5α-dihydroprogesterone were purchased from Steraloids (Newport, RI). ASD, 5α-
diol, T, DHEA, 5α-ASD, DHT, AND, d3-methanol, and formic acid (88%, ACS reagent
grade) were purchased from Sigma-Aldrich (St. Louis, MO). Ethanol was obtained from
Pharmco (Brookfield, CT). Ammonium formate and HPLC grade toluene were purchased
from Fisher Scientific (Fairlawn, NJ). Methanol was purchased from Caledon Laboratories
(Georgetown, Ontario, Canada). Deionized water was obtained from a Hydro Services
Picopure 2 water system (Durham, NC).
Methods
Chromatography
An Agilent 1100 capillary LC system (Santa Clara, CA) was used for separation. The
column was a Luna 3 μm C18(2) 100 Å from Phenomenex (Torrance, CA) with dimensions
150 × 2 mm. Solutions were filtered through a 0.45 μm pore size membranes using a
vacuum aspirator. Millipore (Bedford, MA) HAWP mixed cellulose ester membranes were
used for aqueous solutions and Alltech (Deerfield, IL) PTFE membranes were used for
methanolic solutions. Mobile phase A was 2 mM ammonium formate, pH 3.1, in water, and
mobile phase B was 2 mM ammonium formate, pH 3.1, in methanol. Stock solutions of 20
mM ammonium formate were prepared by dissolving 120 mg ammonium formate in 500
mL of water or methanol, followed by the addition of 307 μL formic acid. Stocks were kept
at 4°C and were diluted and filtered prior to use. Diluted solutions were discarded after one
week. Stocks were discarded after four weeks. Gradient elution was performed at a flow rate
of 175 μL/min and a column temperature of 60 °C. The gradient was run from 65% B at 0
min. to 80% B at 2.25 min., to 95% B at 13 min, 100% B at 13.1 min then reduced to 65% B
at 17.5 min.
Mass Spectrometry
Mass spectrometry was performed on an MDS Sciex API-3000 triple quadrupole
instrument. A Turbo IonSpray source was used for ESI experiments, a PhotoSpray source
was used for dopant assisted APPI experiments, and a heated nebulizer source was used for
APCI experiments. A Gilson 305 pump was used to deliver toluene as dopant for APPI at 20
μL/min. All experiments were performed in the positive ion mode. The source voltage was
set to 4500 V for ESI and 1375 V for APPI. Source temperature was set to 350° C. Nitrogen
auxiliary gas was delivered at 75 psi for APPI experiments and a flow rate of 7 L/min for
ESI experiments.
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Source parameters and ion pairs used for SRM quantitation and confirmation varied with the
ionization technique used (Table 1). All ions were singly charged. Two parent / fragment
pairs were monitored for each analyte. The more abundant pair was used for quantitation
and the second pair was used for identity confirmation. Acquisition was split into three time
windows, with ASD, T, 5α-diol, and DHEA eluting in the first window, 5α-ASD and DHT
in the second, and AND in the third. Dwell time was increased by monitoring SRM pairs
only during the time a target analyte elutes, which reduced background noise levels. Dwell
times were adjusted for a minimum of 16 data points across each chromatographic peak. The
LOQs were defined as a signal to noise ratio > 3. For determination of the calibration
curves, samples were reconstituted in 100 μL of 65% acetonitrile. The injection volume was
12 uL and the amounts injected on-column were 0.5 - 150 pg for ASD and T, 5 – 1500 pg
for Adiol, 10 – 3000 pg for DHEA and DHT, 40 – 12000 pg for 5α-ASD, and 2 - 600 pg for
AND. Analyses were performed in triplicate.
Results and Discussion
In our previous quantitative study of T and DHT in recurrent CaP specimens,7 we were
successful at quantifying suitably low levels of T and DHT using electrospray ionization.
However, as our interest included quantitation of the components of the androgen cycle and
in specific sub-areas of CaP tissue, the increased number of components to be analyzed and
the reduced tissue sample amounts led us to explore means of improving our quantitation
limits. Steroids, especially α,β-unsaturated keto-steroids, have been reported to form [M +
H]+ ions efficiently under APPI conditions.20, 24 APPI has also been reported to reduce
background levels compared with ESI.20 Finally, APPI tends to be less susceptible to matrix
effects.26, 28 For these reasons, we decided to explore the applicability of APPI for analysis
of tissue androgens.
For the initial experiment, we analyzed a solution containing 2 ng each of T and DHT and
monitored the masses of the [M + H]+ ions of each. The selected ion chromatograms (SIC)
of the [M + H]+ ions of T and DHT using APPI (Supplemental Fig. 1A and 1B,
respectively) compared to ESI (Supplemental Fig. 1C and 1D, respectively) showed that the
overall ion currents of T obtained by APPI and ESI were comparable (6.96e6, ESI; 6.66e6,
APPI). However the S:N for T by APPI was five-fold greater than that for T by ESI. In
contrast, the ion current of the DHT [M + H]+ ion was a factor of five greater by ESI
(1.05e6) than by APPI (0.2e6). APPI noise levels were roughly half that of ESI, leading to a
2.5 fold decrease in S:N via APPI vs. ESI. A similar decrease in DHT sensitivity using APPI
was reported by Yamamoto, et al.24
The full scan mass spectra of DHT under ESI (Fig. 1A) and APPI conditions (Fig. 1B) were
acquired and inspected to see if water loss, as has been noted for sterols12, could explain, at
least in part, the loss in sensitivity under APPI conditions. Electrospray ionization of DHT in
a water : methanol solution resulted in an abundant protonated DHT ion (Fig. 1A). Although
a minor amount of [M + H - H2O]+ was observed in the APPI spectrum (Fig. 1B), the most
abundant ion observed was an ion with a mass 14 Da (m/z 305) above the mass of
protonated DHT (m/z 291). This is in contrast to the behavior of T where a protonated ion
was observed using both APPI and ESI (data not shown). The data suggested that a reaction
occurred during the APPI process. The androgens of interest also contained a second
saturated keto-steroid, 5α-ASD. Examination of the APPI mass spectrum of 5α-ASD
identified an [M + 15]+ ion as the parent ion (Fig. 1C). Furthermore, the saturated keto-
steroids 5α-dihydroprogesterone (Fig. 1D) and 5α-androstan-3-one (Fig. 1E) form [M + 15]+
ions when subjected to dopant assisted photoionization. Thus, this ionization mechanism
appears general for α,β-saturated-keto-steranes. The simpler saturated ketones
cyclohexanone and 2-octadecanone were also investigated and found to form [M + 15]+ ions
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under these conditions. The APPI spectra of α,β-saturated sterols, 5α-diol, DHEA and AND
were dominated by the [M + H - H2O]+ ions (data not shown). No significant peak due to
formation of an [M + 15 – H2O]+ ion was observed in the spectra of the hydroxy-
ketosteroids, DHEA or AND.
Origin and behavior of the [M + 15]+ ion
A likely potential source of the [M + 15]+ ion is via reaction of the keto-sterane in the APPI
source with methanol from the chromatographic mobile phase. Nucleophilic attack of the
keto oxygen by methanol would result in a hemiketal. Subsequent protonation and
dehydration would yield the observed [M + 15]+ ion (Scheme A; note that protonation may
occur at steps other than that used for illustrative purposes). The product ion spectrum of the
ESI produced [M + H]+ ion of DHT (Fig. 2A) is similar to the product ion spectrum of the
APPI produced [M + 15]+ ion of DHT (Fig. 2B). However, a fragment of m/z 85 which is
absent in the [M + H]+ product spectrum is present in the [M + 15]+ product spectrum. The
APPI parent ion mass shifts to [M + 18]+ in trideutero-methanol (Fig. 2C) and to [M + 29]+
in ethanol (Fig. 2D), confirming alkyl addition from the mobile phase and the identity of the
[M + 15]+ parent ion as [M + CH3]+.
Further evidence for the structure of the [M + 15]+ ion is provided by the m/z 85 fragment
ion. This fragment ion also shifts with the change in mobile phase, indicating it contains the
modified portion of the parent molecule. In addition, the fragment is observed at m/z 88
from 1,2,4,5-d4-DHT (Fig. 2E) but remains at m/z 85 in the CID spectrum of 16,16,17-d3-
DHT (Fig. 2F). Thus the modification is confirmed to be in the A-ring of DHT. A proposed
fragment structure is shown in the Scheme. The m/z 85 ion was used as the confirmatory ion
and the base fragment ion, m/z 255 for DHT and m/z 253 for 5α-ASD, was used for
quantitation.
The most abundant species in the APPI spectrum of 5α-cholestan-3-one is the [M + 15]+ ion
but [M - 17]+ is the most abundant for 5β-cholestan-3-one (Supplemental Figure S2). We
hypothesize that the formation of this ion occurs through initial formation of the [M + CH3]+
which then undergoes loss of CH3OH due to steric hindrance in the β-isomer. This behavior
may be useful for assessing the stereospecificity of syntheses of saturated keto products.
LC optimization
Experimental evidence suggests methylation occurs both in the APPI source and during
chromatography when using methanolic solutions. 85% methanol was used for isocratic
chromatography experiments. The primary [M + 15]+ ion peak observed with APPI is at the
same retention time (4.1 min) as the [M + H]+ peak observed with ESI (Fig. 3A, 3B), which
suggests that methylation occurs within the APPI source. However, when chromatography
was performed with 0.1% formic acid mobile phase modifier and APPI, an elevated level of
[M + 15]+ continued to elute after the DHT chromatographic peak (Fig. 3B, tailing peak). A
second [M + 15]+ maximum was observed before the baseline returned to background level.
This behavior was not observed under the same chromatographic conditions when
monitoring the [M + H]+ species in conjunction with ESI (Fig. 3A). Taken together, these
data indicate that the methylation of keto-steranes occurred both on the chromatography
column and in the APPI source. When 2 mM ammonium formate was used as a mobile
phase modifier, on-column methylation was minimized (Fig. 3C). Even with the addition of
2 mM ammonium formate, however, a second [M + 15]+ peak was observed in the
chromatogram (7.1 min) when the analyte was solvated in 50% methanol prior to injection.
The peak was eliminated when the analyte was solvated in 50% acetonitrile (Fig. 3D). This
in-solution methylation would be unobserved in methods utilizing ESI and SIM or SRM
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targeting the [M + H]+ species and has potential to negatively impact the sensitivity and
reproducibility of such methods.
Peak height was reduced to ~40% in ammonium formate modified buffer compared to
formic acid modified mobile phase (Fig. 3B, 3C). However, a linear calibration was
achieved for DHT with ammonium formate solution, which could not be achieved in formic
acid solution. Using ammonium formate as the mobile phase modifier, a gradient LC
method was developed that achieved baseline separation of all analytes except T and 5α-diol
in 13 minutes (Fig. 4). These two analytes differ in mass and coelution was deemed
acceptable given the low interference potential.
SRM quantitation
The limits of quantitation by selected reaction monitoring (SRM) of the transitions under
optimized instrument parameters for the seven androgens studied are shown in Table 1.
Linear calibration curves were obtained under APPI conditions for ASD, T, 5α-Diol, DHEA,
5α-ASD DHT, and AND. Calibration ranges were 0.5 - 150 pg on column for ASD and T, 5
– 1500 pg for 5α-Diol, 10 – 3000 pg for DHEA and DHT, 40 – 12000 pg for 5α-ASD, and 2
- 600 pg for AND. The coefficient of determination was >0.994 for all analytes.
Concentrations were calculated based on the ratio of the area of the analyte chromatographic
peak to the area of the internal standard peak. The limit of quantitation was defined as a
peak height 3 times that of the peak to valley noise (S/N > 3) and less than 15% variation in
calculated concentrations. APPI detection levels for the saturated keto-androgens using these
parameters were within 2-fold of those obtained by ESI, while detection levels improved
2-4-fold for the other target analytes.
Application to CaP cell culture and rat prostate tissue
The LC/APPI/MS/MS method was applied for analysis of androgens in cell culture and rat
prostate tissue and compared to LC/ESI/MS/MS. The APPI results for androgens isolated
from CaP cell culture media (Table 2) were based on triplicate injections of three
experimental replicates. These samples constituted a relatively simple matrix. The
concentrations measured using APPI and ESI agreed to within 15% or less, with the
exception of AND which varied ~20% at maximum. DHEA produced S:N < 3 in ESI
experiments. When the methods were applied to rat prostate tissue, T sensitivity during
APPI was 3-fold higher than for ESI (Fig. 5A, 5C) and T became the largest peak in the
chromatogram. Good agreement was obtained for concentrations of ASD and T. The
increased sensitivity of the APPI method allowed quantitation of DHEA. However, a 4-fold
drop in sensitivity for DHT was seen with APPI compared to ESI (Fig. 5B, 5D) and DHT
levels were close to the APPI limit of quantitation.
Application to prostate tissue
Comparative data was also obtained from human clinical samples (Table 2). Chromatograms
representative of the APPI results are shown in Fig. 6A-G. The SRM spectrum for
quantitation of the DHT level in a tissue sample (Fig. 6A) showed that DHT can be detected
at ng/g concentrations in 50mg recurrent CaP tissue. These results are consistent with the
results previously reported for T and DHT.7 Additionally, quantifiable levels of ASD,
DHEA and AND were observed in CaP tissue. These androgens are potential additional
sources of DHT in recurrent CaP.
Despite the increased relative sensitivity for DHT by ESI, The d3-DHT internal standard
was subject to interference in the ESI analysis of human prostate peripheral and transition
zone isolates (Fig. 7A), such that subtraction of the larger background ion gave an
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artifactually lower d3-DHT abundance. This resulted in elevated calculated concentrations of
DHT. The APPI analysis was not subject to this interference (Fig 7B).
Conclusions
An LC/APPI/MS/MS method for the separation and quantitative analysis of seven
androgens of interest for recurrent CaP research was developed and compared to an LC/ESI/
MS/MS approach. Identification of a novel keto-derivative formed via a loss of water from a
hemiketal formed during the APPI process led to improved LC/APPI/MS/MS sensitivity for
the saturated keto-androgens DHT and 5α-ASD, which are important in prostate tissue
androgen intracrine metabolism.
Formation of the keto derivative was also observed to a lesser extent during ESI analysis of
keto-steroids either dissolved in methanol or when methanol was used as a component of the
LC solvent. The formation of this derivative may give rise to reduced signal intensities in
quantitative analyses based on the expected [M + H]+ ion, and may also explain some mass
spectral peaks unaccounted for in previously obtained spectra. The APPI method offers
advantages in specificity and limits of quantitation over methods using RIA, GC/MS, & LC/
ESI/MS/MS.
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The mass spectra of 5α-reduced androgens using ESI and APPI conditions. A) ESI)
spectrum of DHT. The APPI spectra of B) DHT, C) 5α-ASD, D) dihydroprogesterone and
E) 5α-androstan-3-one.
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Product spectra of DHT. A) ESI produced [DHT + H]+. B) APPI produced [DHT + 15]+. C)
DHT in trideutero-methanol. D) DHT in ethanol. E) 1,2,4,5-d4-DHT. F) 16,16,17-d3-DHT.
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Extracted ion chromatograms of DHT in 85% methanol. A) [DHT+H]+ using 0.1% formic
acid mobile phase modifier and ESI; B) Methylated DHT adduct [DHT+CH3]+ using APPI ,
peak tailing was due to on-column methylation of DHT; C) Methylated DHT adduct [DHT
+CH3]+ using APPI and ammonium formate buffer showed minimized on-column
methylation and improved peak shape; D) Methylated DHT adduct [DHT+CH3]+ using
APPI and solvation of DHT in acetonitrile rather than methanol eliminated the secondary
methylated DHT chromatographic peak.
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LC/ESI/MS/MS total ion chromatogram demonstrated baseline separation for six of seven
androgens, ASD, T, DHEA, 5α-ASD, DHT and AND. 5α-diol co-eluted with T but can be
discriminated based upon mass. The vertical bars represent transitions to new SRM
acquisition windows.
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Selected reaction monitoring analyses of T and DHT using APPI (A and B) or ESI (C and
D), respectively (cps = counts per second).
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Analyses of seven androgens in a recurrent CaP tissue using APPI and selected reaction
monitoring: A) ASD, 7.4 minutes, B) T, 8.3 minutes, C) AND, 11.6 minutes, D) DHEA, 9.1
minutes, E) 5α-ASD, 9.8 minutes, F) DHT, 10.29 minutes, and G) 5α-diol, 8.31 minutes.
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Interference in the selected reaction monitoring of d3-DHT prevented quantitation from the
electrospray ionization results. Interference was not a problem with photoionization.
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